Advertisement
Screener

BIOTRICITY INC. (BTCY) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

2.6 / 5 stars · 40/76 Roast Me

BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

BIOTRICITY INC. (BTCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 147.15 thousand shares for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-07-14

  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-03-31 was 69.00 shares.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-12-31 was 531.28K shares.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-09-30 was 118.28K shares, a 73.02% decline year-over-year.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-06-30 was 53.83K shares, a 10.29% decline year-over-year.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2026 was 147.15K shares, a 91.83% decline from fiscal 2025.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 1.80M shares, a 92.07% increase from fiscal 2024.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 937.16K shares, a 1338.49% increase from fiscal 2023.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 65.15K shares, a 89.88% decline from fiscal 2022.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 14 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 15 month
2026-03-31147.15K shares
10-K · filed 2026-07-14
2025-03-311.80M shares
10-K · filed 2026-07-14
2024-03-3169.00 shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-07-18
937.16K shares
10-K/A · filed 2025-07-18
2023-12-31937.09K shares
10-Q · filed 2024-02-20
2023-03-3165.15K shares
10-K · filed 2024-06-27
390.89K shares
10-K · filed 2023-06-29
2022-12-31531.28K shares
10-Q · filed 2023-02-14
649.57K shares
derived: sum of 2 quarters · filed 2023-02-14
703.39K shares
derived: sum of 3 quarters · filed 2023-02-14
2022-09-30118.28K shares
10-Q · filed 2023-02-14
172.11K shares
derived: sum of 2 quarters · filed 2023-02-14
2022-06-3053.83K shares
10-Q · filed 2023-02-14
2022-03-31643.53K shares
10-K · filed 2023-06-29
2021-09-30438.40K shares
10-Q · filed 2022-02-14
498.40K shares
derived: sum of 2 quarters · filed 2022-02-14
2021-06-3060.00K shares
10-Q · filed 2022-02-14
2021-03-317.15M shares
10-K · filed 2022-07-14
2020-12-31226.67K shares
10-Q · filed 2021-02-16
299.58K shares
derived: sum of 2 quarters · filed 2021-02-16
349.58K shares
derived: sum of 3 quarters · filed 2021-02-16
557.92K shares
derived: sum of 4 quarters · filed 2021-02-16
2020-09-3072.92K shares
10-Q · filed 2021-02-16
122.92K shares
derived: sum of 2 quarters · filed 2021-02-16
331.25K shares
derived: sum of 3 quarters · filed 2021-02-16
899.25K shares
derived: sum of 4 quarters · filed 2021-02-16
2020-06-3050.00K shares
10-Q · filed 2021-02-16
258.33K shares
derived: sum of 2 quarters · filed 2021-02-16
826.33K shares
derived: sum of 3 quarters · filed 2021-02-16
1.14M shares
derived: sum of 4 quarters · filed 2021-02-16
2020-03-31208.33K shares
10-Q · filed 2021-02-16
58.33K shares
10-Q · filed 2020-08-14
776.33K shares
derived: sum of 2 quarters · filed 2021-02-16
1.09M shares
derived: sum of 3 quarters · filed 2021-02-16
1.02M shares
10-K · filed 2022-07-14
2019-12-31568.00K shares
10-Q · filed 2021-02-16
879.35K shares
derived: sum of 2 quarters · filed 2021-02-16
963.10K shares
derived: sum of 3 quarters · filed 2021-02-16
1.30M shares
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30311.35K shares
10-Q · filed 2021-02-16
395.10K shares
derived: sum of 2 quarters · filed 2021-02-16
736.37K shares
derived: sum of 3 quarters · filed 2021-02-16
786.37K shares
derived: sum of 4 quarters · filed 2021-02-16
2019-06-3083.75K shares
10-Q · filed 2021-02-16
425.02K shares
derived: sum of 2 quarters · filed 2021-02-16
475.02K shares
derived: sum of 3 quarters · filed 2021-02-16
868.35K shares
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31341.27K shares
10-Q · filed 2020-11-13
391.27K shares
derived: sum of 2 quarters · filed 2020-11-13
784.60K shares
derived: sum of 3 quarters · filed 2020-11-13
849.60K shares
10-K · filed 2020-07-15
2018-12-3150.00K shares
10-Q · filed 2020-11-13
443.33K shares
derived: sum of 2 quarters · filed 2020-11-13
508.33K shares
derived: sum of 3 quarters · filed 2020-11-13
2018-09-30393.33K shares
10-Q · filed 2020-11-13
458.33K shares
derived: sum of 2 quarters · filed 2020-11-13
2018-06-3065.00K shares
10-Q · filed 2020-11-13
2018-03-314.03M shares
10-K · filed 2020-07-15
2017-03-311.32M shares
10-K · filed 2019-07-16
1.32M shares
10-K · filed 2020-07-15